162,674 research outputs found
Liggett and Myers Premium Store Exterior
No full textImage shows the exterior of the Liggett and Myers Premium Store
Liggett and Myers Premium Store Interior
No full textImage shows the interior of the Liggett and Myers Premium Store
[Report to Chief J. E. Curry, by an unknown author #1]
No full textReport to Chief J. E. Curry, by an unknown author. The report contains a list of officers who gave depositions to the United States Attorney
[Report to Chief J. E. Curry, by an unknown author #2]
No full textReport to Chief J. E. Curry, by an unknown author. The report contains a list of officers who gave depositions to the United States Attorney
Chaplines from Maryland and Virginia, by Maria J. Liggett Dare.
No full text3 p. l., 113, xiii p., 1 l
Murder on the mountain: author talk with Peter J. Wosh
No full textAuthor talk by Peter J. Wosh on May 5th, 2022, on his book, "Murder on the Mountain: crime, passion, and punishment in gilded age New Jersey.
Mr. Melvin J. Collier, RWWL AUC, June 2011
No full textThis video is a conversation with Mr. Melvin J. Collier. Mr. Collier talks about his book, "From Mississippi to Africa: A Journey of Discovery". Daniel Le, AUC Woodruff Library, is the interviewer
Recommended from our members
Nonlinear semigroup theory for systems
No full textThe abstract Cauchy problem in a B-space is considered. Under certain conditions, and with use of the Generation Theorem of Crandall and Liggett (Am. J. Math., 93, 265-298 (1971)), the finite difference problem has a unique solution on (0,infinity). The author works here to extend the application of the Crandall-Liggett theorem to two conservation laws with linear coupling. (RWR
Solar Energy Development Assistance for Fort Hunter Liggett
No full textPacific Northwest National Laboratory provided assistance to Fort Hunter Liggett to determine the opportunities for solar energy development on the site. Increasing use of renewable energy is mandated by several executive orders and legislation. Fort Hunter Liggett has many attributes that enhance its suitability for renewable energy development. First, the site is located south of San Francisco in a remote portion of the costal foothills. Brush and forest fires are frequent and often result in power outages, which subsequently impacts the site’s training mission. In addition, the site’s blended electric rate during fiscal year (FY) 2010 was high at 12 ¢/kWh. Lastly, the solar resource is moderately high; the site receives nearly 5.7 kWh/m2/day on a south facing, latitude-tilted surface. In light of these factors, the site is a clear candidate for a solar photovoltaic array. Prior to Pacific Northwest National Laboratory’s (PNNL) involvement, the site secured funding for a 1 megawatt (MW) photovoltaic (PV) array that will also provide shading for site vehicles. To best implement this project, PNNL conducted a site visit and was tasked with providing the site technical guidance and support regarding module selection, array siting, and other ancillary issues
Pharmacogenetics of ophthalmic topical β-blockers
No full textGlaucoma is the second leading cause of blindness worldwide. The primary glaucoma risk factor is elevated intraocular pressure. Topical β-blockers are affordable and widely used to lower intraocular pressure. Genetic variability has been postulated to contribute to interpersonal differences in efficacy and safety of topical β-blockers. This review summarizes clinically significant polymorphisms that have been identified in the β-adrenergic receptors (ADRB1, ADRB2 and ADRB3). The implications of polymorphisms in CYP2D6 are also discussed. Although the candidate-gene approach has facilitated significant progress in our understanding of the genetic basis of glaucoma treatment response, most drug responses involve a large number of genes, each containing multiple polymorphisms. Genome-wide association studies may yield a more comprehensive set of polymorphisms associated with glaucoma outcomes. An understanding of the genetic mechanisms associated with variability in individual responses to topical β-blockers may advance individualized treatment at a lower cost
- …
